- Report
- May 2024
- 105 Pages
North America
From €2573EUR$2,950USD£2,231GBP
- Report
- May 2024
- 97 Pages
Middle East, Africa
From €2573EUR$2,950USD£2,231GBP
- Report
- May 2024
- 122 Pages
Europe
From €3009EUR$3,450USD£2,609GBP
- Report
- May 2024
- 118 Pages
Asia Pacific
From €3009EUR$3,450USD£2,609GBP
- Database
- February 2023
Canada
From €6541EUR$7,500USD£5,673GBP
- Report
- September 2022
- 276 Pages
Global
From €3489EUR$4,000USD£3,025GBP
- Database
- July 2020
France
From €6541EUR$7,500USD£5,673GBP
- Report
- January 2020
- 30 Pages
China
From €1919EUR$2,200USD£1,664GBP
- Report
- November 2018
- 98 Pages
Latin America
From €6541EUR$7,500USD£5,673GBP
- Database
- October 2018
Malaysia
€6541EUR$7,500USD£5,673GBP
- Report
- August 2024
- 95 Pages
Global
From €3500EUR$4,299USD£3,141GBP
- Report
- August 2023
- 103 Pages
Global
From €3500EUR$4,299USD£3,141GBP
- Report
- August 2022
- 102 Pages
Global
From €3500EUR$4,299USD£3,141GBP
- Report
- October 2023
- 146 Pages
Global
From €3619EUR$4,150USD£3,139GBP
- Report
- October 2024
- 85 Pages
Global
From €3500EUR$4,299USD£3,141GBP
- Report
- October 2024
- 83 Pages
Global
From €3500EUR$4,299USD£3,141GBP
- Report
- August 2024
- 92 Pages
Global
From €3500EUR$4,299USD£3,141GBP
- Report
- July 2023
- 105 Pages
Global
From €3500EUR$4,299USD£3,141GBP
- Report
- June 2023
- 90 Pages
Global
From €3500EUR$4,299USD£3,141GBP
- Report
- April 2022
- 84 Pages
Global
From €3500EUR$4,299USD£3,141GBP

The Transplantation market within the context of Biotechnology is focused on the development of treatments and technologies that enable the successful transfer of organs, tissues, and cells from one individual to another. This includes the development of new methods for organ preservation, the development of new immunosuppressive drugs, and the development of new technologies for organ matching. Additionally, the market is focused on the development of new methods for organ harvesting, as well as the development of new methods for organ transplantation.
The Transplantation market is a rapidly growing sector of the biotechnology industry, with many companies investing in research and development to improve the success rate of organ transplants. Companies in this market include Organogenesis, Organovo, Histogenics, and United Therapeutics. Additionally, many pharmaceutical companies are investing in the development of new immunosuppressive drugs to improve the success rate of organ transplants. Show Less Read more